Wu H - Search Results

1

Long-acting HIV fusion inhibitor albuvirtide combined with ritonavir-boosted lopinavir for HIV-1-infected patients after failing the first-line antiretroviral therapy: 48-week randomized, controlled, phase 3 non-inferiority TALENT study.

Su B, Yao C, Zhao QX, Cai WP, Wang M, Lu HZ, Mu TT, Chen YY, Liu L, Wang H, He Y, Zheng YH, Li LH, Chen JF, Yu JH, Zhu B, Zhao M, Sun YT, Lun WH, Zhang YH, Wang H, Xia W, Sun LJ, Dai LL, Jiang TY, Wang MX, Zheng QS, Peng HY, Wang Y, Hu M, Liu X, Lu RJ, Hu JH, Sun CC, Xing H, Shao YM, Xie D, Zhang T, Zhang FJ, Wu H. Su B, et al. Among authors: wu h. J Infect. 2022 Sep;85(3):334-363. doi: 10.1016/j.jinf.2022.05.034. Epub 2022 Jun 1. J Infect. 2022. PMID: 35659547 No abstract available.

2

Combination of long-acting HIV fusion inhibitor albuvirtide and LPV/r showed potent efficacy in HIV-1 patients.

Zhang H, Jin R, Yao C, Zhang T, Wang M, Xia W, Peng H, Wang X, Lu R, Wang C, Xie D, Wu H. Zhang H, et al. Among authors: wu h. AIDS Res Ther. 2016 Feb 10;13:8. doi: 10.1186/s12981-016-0091-1. eCollection 2016. AIDS Res Ther. 2016. PMID: 26865854 Free PMC article. Clinical Trial.

3

Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1: interim analysis of the randomized, controlled, phase 3, non-inferiority TALENT study.

Su B, Yao C, Zhao QX, Cai WP, Wang M, Lu HZ, Chen YY, Liu L, Wang H, He Y, Zheng YH, Li LH, Chen JF, Yu JH, Zhu B, Zhao M, Sun YT, Lun WH, Xia W, Sun LJ, Dai LL, Jiang TY, Wang MX, Zheng QS, Peng HY, Wang Y, Lu RJ, Hu JH, Xing H, Shao YM, Xie D, Zhang T, Zhang FJ, Wu H; TALENT Study Team. Su B, et al. Among authors: wu h. Chin Med J (Engl). 2020 Nov 25;133(24):2919-2927. doi: 10.1097/CM9.0000000000001273. Chin Med J (Engl). 2020. PMID: 33252379 Free PMC article. Clinical Trial.

4

Liver injury in HIV-1-infected patients receiving non-nucleosides reverse transcriptase inhibitors-based antiretroviral therapy.

Li ZC, Li HJ, Dai LL, Gao YQ, Cai WP, Li HY, Huang XJ, Zhang T, Wu H. Li ZC, et al. Among authors: wu h. Chin Med J (Engl). 2010 Dec;123(24):3587-90. Chin Med J (Engl). 2010. PMID: 22166636

5

Burden of sleep disturbances and associated risk factors: A cross-sectional survey among HIV-infected persons on antiretroviral therapy across China.

Huang X, Li H, Meyers K, Xia W, Meng Z, Li C, Bai J, He S, Cai W, Huang C, Liu S, Wang H, Ling X, Ma P, Tan D, Wang F, Ruan L, Zhao H, Wei H, Liu Y, Yu J, Lu H, Wang M, Zhang T, Chen H, Wu H. Huang X, et al. Among authors: wu h. Sci Rep. 2017 Jun 16;7(1):3657. doi: 10.1038/s41598-017-03968-3. Sci Rep. 2017. PMID: 28623361 Free PMC article.

6

Lack of HIV-1 integrase inhibitor resistance among 392 antiretroviral-naïve individuals in a tertiary care hospital in Beijing, China.

Liu L, Dai L, Yao J, Pan P, Li L, Liu Z, An X, Sun L, Wu H, Su B, Zhang T. Liu L, et al. Among authors: wu h. AIDS. 2019 Oct 1;33(12):1945-1947. doi: 10.1097/QAD.0000000000002282. AIDS. 2019. PMID: 31491787

7

Impact of Lopinavir/Ritonavir and Efavirenz-Based Antiretroviral Therapy on the Lipid Profile of Chinese HIV/AIDS Treatment-Naïve Patients in Beijing: A Retrospective Study.

Dai L, Liu A, Zhang H, Wu H, Zhang T, Su B, Shao Y, Li J, Ye J, Scott SR, Mahajan SD, Schwartz SA, Yu H, Sun L. Dai L, et al. Among authors: wu h. Curr HIV Res. 2019;17(5):324-334. doi: 10.2174/1570162X17666191025115508. Curr HIV Res. 2019. PMID: 31654514

8

Efficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China.

Su B, Wang Y, Zhou R, Jiang T, Zhang H, Li Z, Liu A, Shao Y, Hua W, Zhang T, Wu H, He S, Dai L, Sun L. Su B, et al. Among authors: wu h. Front Pharmacol. 2019 Dec 12;10:1472. doi: 10.3389/fphar.2019.01472. eCollection 2019. Front Pharmacol. 2019. PMID: 31920659 Free PMC article.

9

Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non-responders.

Yang X, Su B, Zhang X, Liu Y, Wu H, Zhang T. Yang X, et al. Among authors: wu h. J Leukoc Biol. 2020 Apr;107(4):597-612. doi: 10.1002/JLB.4MR1019-189R. Epub 2020 Jan 22. J Leukoc Biol. 2020. PMID: 31965635 Free PMC article. Review.

10

Adverse events in Chinese human immunodeficiency virus (HIV) patients receiving first line antiretroviral therapy.

Dai L, Su B, Liu A, Zhang H, Wu H, Zhang T, Shao Y, Li J, Ye J, Bai S, Guo X, Sun L. Dai L, et al. Among authors: wu h. BMC Infect Dis. 2020 Feb 19;20(1):158. doi: 10.1186/s12879-020-4878-2. BMC Infect Dis. 2020. PMID: 32075584 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43,843 results

Search Page